Position in MRK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$683,363
+$43,661 QoQ
Shares Held
5,318
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2,441
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZEVIN ASSET MANAGEMENT LLC holds $59,856,217 across 9 Drug Manufacturers - General names. MRK ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
76,892 | $19,349,102 | |
| 2 | LLY |
ELI LILLY & Co
|
12,300 | $14,752,990 | |
| 3 | NVS |
Novartis AG
|
74,291 | $11,642,885 | |
| 4 | AZN |
Astrazeneca PLC
|
58,678 | $11,126,522 | |
| 5 | AMGN |
Amgen Inc
|
3,256 | $1,179,062 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
5,318 | $683,363 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,006 | $506,118 | |
| 8 | PFE |
Pfizer Inc
|
14,641 | $352,555 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $683,363 | 5,318 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $639,702 | 5,318 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $559,772 | 5,318 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $462,118 | 5,506 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $435,854 | 5,506 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $655,786 | 7,306 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $778,431 | 7,825 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $682,609 | 6,011 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $744,161 | 6,011 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $793,151 | 6,011 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $923,508 | 8,471 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $872,089 | 8,471 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $881,118 | 7,636 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $828,352 | 7,786 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $869,404 | 7,836 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $674,836 | 7,836 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $714,408 | 7,836 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $708,583 | 8,636 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $513,947 | 6,706 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $507,893 | 6,762 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $521,525 | 6,706 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $447,122 | 5,800 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $477,793 | 5,841 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $484,511 | 5,841 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $389,820 | 5,041 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $387,854 | 5,041 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||